Reuters logo
BRIEF-BioPharmX completes enrollment of Phase 2B OPAL trial for acne vulgaris
January 4, 2017 / 2:26 PM / a year ago

BRIEF-BioPharmX completes enrollment of Phase 2B OPAL trial for acne vulgaris

Jan 4 (Reuters) - BioPharmX Corp :

* BioPharmX completes enrollment of BPX-01 Phase 2B OPAL clinical trial for acne vulgaris

* BioPharmX Corp - expect trial results will be available in first half of 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below